KRAS and hepatocellular carcinoma: Although the heterogeneous etiology of LC and HCC poses a challenge in the definition of a driver mutation panel [48], we detected only a few (and at low frequency) of the established HCC driver mutations such as TP53, CTNNB1, KRAS, PIK3CA or TERT.